Group One Trading’s Cabaletta Bio CABA Stock Holding History

Group One Trading’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,669	Closed	-$120K	–	6687
2024 Q2	$155K	Buy	+20,669	New	+$253K	﹤0.01%	3614
2024 Q1	–	Sell	-3,397	Closed	-$72.9K	–	7098
2023 Q4	$77.1K	Buy	+3,397	New	+$57.1K	﹤0.01%	4690
2022 Q4	–	Sell	-6,373	Closed	-$23.2K	–	7284
2022 Q3	$4K	Buy	+6,373	New	+$7.67K	﹤0.01%	6896
2022 Q1	–	Sell	-200	Closed	-$523	–	8062
2021 Q4	$1K	Hold	200	–	–	﹤0.01%	7971
2021 Q3	$2K	Buy	+200	New	+$1.84K	﹤0.01%	7924

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Group One Trading's CABA Position: Q3 2024 in Review

Group One Trading sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 20,669 shares — an estimated $120K sold.

Group One Trading first reported a position in CABA in Q3 2021 and held it in 5 quarters. The position peaked at $155K in Q2 2024. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

Group One Trading reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
Group One Trading sold 20,669 Cabaletta Bio shares in Q3 2024, an estimated $120K.
Group One Trading first reported a position in Cabaletta Bio in Q3 2021 and held it in 5 quarters.
Group One Trading's Cabaletta Bio position peaked at $155K in Q2 2024.
120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.